Page 2 - Norgine Annual Report 2017
P. 2

Norgine has established three priorities that sit alongside
                                                                                                                                                                           the overall vision:

                                                                                                                                                                           Achieve sustainable
                                                                                                                                                                           double-digit growth

                                                                                                                                                                           Norgine strives to achieve double digit growth by maximising
                                                                                                                                                                           the growth of its products: DANTRIUM , ENDOCUFF VISION ,
                                                                                                                                                                           LYMPHOSEEK , MOVICOL , MOVIPREP , PLENVU  and XIFAXAN .
                                                                                                                                                                           Maintain strong late
                                                                                                                                                                           stage pipeline
                                                                                                                                                                           Norgine’s priority is to acquire and develop new late stage products
                                                                                                                                                                           (phase III onwards) that will change medical care and add value to
                                                                                                                                                                           patients and healthcare systems.
                                Norgine’s vision is to be the ‘go
                                to’ European specialist pharma                                                                                                             Be a dynamic place to work

                                company; the organisation                                                                                                                  Norgine is fostering a dynamic environment which means employees
                                that other companies come                                                                                                                  are encouraged to challenge the status quo and make brave decisions.

                                to in order to develop and                                                                                                                 The core value principles of One Norgine, Innovation
                                commercialise their products.                                                                                                              and Trustworthiness underpin all of Norgine’s activities,

                                                                                                                                                                           and are fundamental to realising the group’s vision.

       1                                                                                                                                                                                                                                2
   1   2   3   4   5   6   7